Welcome to LookChem.com Sign In|Join Free

CAS

  • or

33948-22-0

Post Buying Request

33948-22-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

33948-22-0 Usage

Chemical Properties

Pink Solid

Uses

Different sources of media describe the Uses of 33948-22-0 differently. You can refer to the following data:
1. Dibenz [b,f]azepine-5-carbonyl chloride may be used in the preparation of trans-10,11-dibromo-10,11-dihydro-5H-dibenz[b,f]azepine-5-carbonyl chloride via bromination using bromine. It may also be used to prepare urea derivatives, which are potent P2X4 receptor (purinergic receptor) antagonists.
2. An intermediate in the preparation of Carbamazepine.

General Description

Dibenz [b,f]azepine-5-carbonyl chloride or 5H-dibenz [b,f]azepine-5-carbonyl chloride is a tricyclic heterocyclic compound that can be synthesized from 5H-dibenz[ b,f]azepine.

Check Digit Verification of cas no

The CAS Registry Mumber 33948-22-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,3,9,4 and 8 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 33948-22:
(7*3)+(6*3)+(5*9)+(4*4)+(3*8)+(2*2)+(1*2)=130
130 % 10 = 0
So 33948-22-0 is a valid CAS Registry Number.
InChI:InChI=1/C15H10ClNO/c16-15(18)17-13-7-3-1-5-11(13)9-10-12-6-2-4-8-14(12)17/h1-10H

33948-22-0 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Aldrich

  • (548644)  Dibenz[b,f]azepine-5-carbonylchloride  95%

  • 33948-22-0

  • 548644-5G

  • 830.70CNY

  • Detail

33948-22-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name Iminostilbene N-Carbonyl Chloride

1.2 Other means of identification

Product number -
Other names Dibenz[b,f]azepine-5-carbonyl chloride

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:33948-22-0 SDS

33948-22-0Synthetic route

10-Brom-5-chlorcarbonyl-5H-dibenzazepin
143667-53-2

10-Brom-5-chlorcarbonyl-5H-dibenzazepin

5H-dibenz[b,f]azepine-5-carbonylchloride
33948-22-0

5H-dibenz[b,f]azepine-5-carbonylchloride

Conditions
ConditionsYield
With tetraethylammonium perchlorate In water; N,N-dimethyl-formamide cathode: Hg, working potential: -1.60 V, charge: 2.0-2.1 F/mol, 4-5 h;92%
10,11-dihydro-dibenzo[b,f]azepine-5-carbonyl chloride
33948-19-5

10,11-dihydro-dibenzo[b,f]azepine-5-carbonyl chloride

5H-dibenz[b,f]azepine-5-carbonylchloride
33948-22-0

5H-dibenz[b,f]azepine-5-carbonylchloride

Conditions
ConditionsYield
With sodium bromate; N-benzyl-N,N,N-triethylammonium chloride; bromine; dibenzoyl peroxide In chlorobenzene at 92 - 97℃; for 8.5h; Temperature; Reagent/catalyst;90.5%
Multi-step reaction with 2 steps
1: Br2 / chlorobenzene / 1.5 h / 145 - 150 °C
2: chlorobenzene / 2 h / 150 - 155 °C
View Scheme
With bromine In chlorobenzene at 80℃; for 6h; Temperature; Inert atmosphere;
dibenzoazepine
256-96-2

dibenzoazepine

bis(trichloromethyl) carbonate
32315-10-9

bis(trichloromethyl) carbonate

5H-dibenz[b,f]azepine-5-carbonylchloride
33948-22-0

5H-dibenz[b,f]azepine-5-carbonylchloride

Conditions
ConditionsYield
With pyridine In 1,2-dichloro-ethane at 75℃; for 3h; Inert atmosphere;75%
In toluene
With pyridine In ethyl acetate n-hexane; dichloromethane
trans-10,11-dibromo-10,11-dihydro-5H-dibenzazepine-5-carbonyl chloride
40421-03-2, 56875-24-2

trans-10,11-dibromo-10,11-dihydro-5H-dibenzazepine-5-carbonyl chloride

5H-dibenz[b,f]azepine-5-carbonylchloride
33948-22-0

5H-dibenz[b,f]azepine-5-carbonylchloride

Conditions
ConditionsYield
In various solvent(s) at 25℃; for 24h;65%
In d7-N,N-dimethylformamide at 25℃; for 24h; Product distribution; variation of reaction solvents, reactant and time;65%
trans-10-bromo-10,11-dihydro-11-hydroxy-5H-dibenzazepine-5-carbonyl chloride
41359-12-0, 66849-41-0

trans-10-bromo-10,11-dihydro-11-hydroxy-5H-dibenzazepine-5-carbonyl chloride

5H-dibenz[b,f]azepine-5-carbonylchloride
33948-22-0

5H-dibenz[b,f]azepine-5-carbonylchloride

Conditions
ConditionsYield
With boron trifluoride diethyl etherate; recorcinol In chloroform at 10℃; for 7h;50%
trans-10-bromo-10,11-dihydro-11-hydroxy-5H-dibenzazepine-5-carbonyl chloride
41359-12-0, 66849-41-0

trans-10-bromo-10,11-dihydro-11-hydroxy-5H-dibenzazepine-5-carbonyl chloride

A

5H-dibenz[b,f]azepine-5-carbonylchloride
33948-22-0

5H-dibenz[b,f]azepine-5-carbonylchloride

trans-10,11-dibromo-10,11-dihydro-5H-dibenzazepine-5-carbonyl chloride
40421-03-2, 56875-24-2

trans-10,11-dibromo-10,11-dihydro-5H-dibenzazepine-5-carbonyl chloride

Conditions
ConditionsYield
With hydrogen bromide In chloroform at 10℃; for 1.5h; Product distribution; variaton of solvents and reactant;A 35%
B 38%
With hydrogen bromide In chloroform at 10℃; for 1.5h;A 35%
B 38%
phosgene
75-44-5

phosgene

dibenzoazepine
256-96-2

dibenzoazepine

5H-dibenz[b,f]azepine-5-carbonylchloride
33948-22-0

5H-dibenz[b,f]azepine-5-carbonylchloride

Conditions
ConditionsYield
In toluene for 0.5h;
In toluene for 5h;
In toluene; Petroleum ether; benzene
In toluene
1a,10b-dihydro-6H-dibenzooxirenoazepine-6-carbonyl chloride
41359-09-5

1a,10b-dihydro-6H-dibenzooxirenoazepine-6-carbonyl chloride

A

5H-dibenz[b,f]azepine-5-carbonylchloride
33948-22-0

5H-dibenz[b,f]azepine-5-carbonylchloride

trans-10,11-dibromo-10,11-dihydro-5H-dibenzazepine-5-carbonyl chloride
40421-03-2, 56875-24-2

trans-10,11-dibromo-10,11-dihydro-5H-dibenzazepine-5-carbonyl chloride

Conditions
ConditionsYield
With hydrogen bromide In chloroform at 10℃; for 3h;
10-bromo-10,11-dihydro-dibenzo[b,f]azepine-5-carbonyl chloride
33948-20-8

10-bromo-10,11-dihydro-dibenzo[b,f]azepine-5-carbonyl chloride

5H-dibenz[b,f]azepine-5-carbonylchloride
33948-22-0

5H-dibenz[b,f]azepine-5-carbonylchloride

Conditions
ConditionsYield
In chlorobenzene at 150 - 155℃; for 2h;
1a,10b-dihydro-6H-dibenzooxirenoazepine-6-carbonyl chloride
41359-09-5

1a,10b-dihydro-6H-dibenzooxirenoazepine-6-carbonyl chloride

5H-dibenz[b,f]azepine-5-carbonylchloride
33948-22-0

5H-dibenz[b,f]azepine-5-carbonylchloride

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 0.55 g / HBr / CHCl3 / 1 h / 10 °C
2: 50 percent / BF3.Et2O, resorcinol / CHCl3 / 7 h / 10 °C
View Scheme
9,10-dihydrodibenzazepine
494-19-9

9,10-dihydrodibenzazepine

5H-dibenz[b,f]azepine-5-carbonylchloride
33948-22-0

5H-dibenz[b,f]azepine-5-carbonylchloride

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 90 percent / toluene / 3.5 h / 90 - 95 °C
2: Br2 / chlorobenzene / 1.5 h / 145 - 150 °C
3: chlorobenzene / 2 h / 150 - 155 °C
View Scheme
Multi-step reaction with 2 steps
1: chlorobenzene / 5 h / 110 °C
2: bromine / chlorobenzene / 6 h / 80 °C / Inert atmosphere
View Scheme
diphenylamine-2,2'-dicarbonyl chloride
32621-46-8

diphenylamine-2,2'-dicarbonyl chloride

5H-dibenz[b,f]azepine-5-carbonylchloride
33948-22-0

5H-dibenz[b,f]azepine-5-carbonylchloride

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: H2 / Palladium-Barium sulphate; Quinolin sulphate / xylene / 2.5 h / Heating
2: 3.8 g / Hydrazine hydrate / acetic acid / 2 h / Heating
3: toluene / 0.5 h
View Scheme
diphenylamine-2,2′-dicarboxaldehyde
49579-63-7

diphenylamine-2,2′-dicarboxaldehyde

5H-dibenz[b,f]azepine-5-carbonylchloride
33948-22-0

5H-dibenz[b,f]azepine-5-carbonylchloride

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 3.8 g / Hydrazine hydrate / acetic acid / 2 h / Heating
2: toluene / 0.5 h
View Scheme
Vanadox
579-92-0

Vanadox

5H-dibenz[b,f]azepine-5-carbonylchloride
33948-22-0

5H-dibenz[b,f]azepine-5-carbonylchloride

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 11.8 g / Thionyl chloride; Pyridine / 5 h / Heating
2: H2 / Palladium-Barium sulphate; Quinolin sulphate / xylene / 2.5 h / Heating
3: 3.8 g / Hydrazine hydrate / acetic acid / 2 h / Heating
4: toluene / 0.5 h
View Scheme
2,2'-dinitrobibenzyl
16968-19-7

2,2'-dinitrobibenzyl

5H-dibenz[b,f]azepine-5-carbonylchloride
33948-22-0

5H-dibenz[b,f]azepine-5-carbonylchloride

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: hydrogen
2: hydrogenchloride / Heating
3: N-Bromosuccinimide
4: toluene
View Scheme
1-methyl-2-nitrobenzene
88-72-2

1-methyl-2-nitrobenzene

5H-dibenz[b,f]azepine-5-carbonylchloride
33948-22-0

5H-dibenz[b,f]azepine-5-carbonylchloride

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: sodium amide
2: hydrogen
3: hydrogenchloride / Heating
4: N-Bromosuccinimide
5: toluene
View Scheme
2,2'-ethylenedianiline
34124-14-6

2,2'-ethylenedianiline

5H-dibenz[b,f]azepine-5-carbonylchloride
33948-22-0

5H-dibenz[b,f]azepine-5-carbonylchloride

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: hydrogenchloride / Heating
2: N-Bromosuccinimide
3: toluene
View Scheme
iodobenzene
591-50-4

iodobenzene

5H-dibenz[b,f]azepine-5-carbonylchloride
33948-22-0

5H-dibenz[b,f]azepine-5-carbonylchloride

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: potassium carbonate; copper(l) iodide; S-pyrrolidine-2-carbaldehyde / dimethyl sulfoxide / 24 h / 90 °C
2: polyphosphoric acid / 100 °C
3: triethylamine / toluene / 6 h
View Scheme
Multi-step reaction with 3 steps
1: potassium carbonate; copper(l) iodide; S-pyrrolidine-2-carbaldehyde / dimethyl sulfoxide / 24 h / 90 °C
2: polyphosphoric acid / 100 °C
3: triethylamine / toluene / 8 h
View Scheme
1-phenyl-1H-indole
16096-33-6

1-phenyl-1H-indole

5H-dibenz[b,f]azepine-5-carbonylchloride
33948-22-0

5H-dibenz[b,f]azepine-5-carbonylchloride

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: polyphosphoric acid / 100 °C
2: triethylamine / toluene / 6 h
View Scheme
Multi-step reaction with 2 steps
1: polyphosphoric acid / 100 °C
2: triethylamine / toluene / 8 h
View Scheme
Multi-step reaction with 2 steps
1: methanesulfonic acid; phosphorus pentoxide / toluene / 6 h / 120 °C
2: toluene / 2.5 h / Reflux; Inert atmosphere
View Scheme
dibenzoazepine
256-96-2

dibenzoazepine

trichloromethyl chloroformate
503-38-8

trichloromethyl chloroformate

5H-dibenz[b,f]azepine-5-carbonylchloride
33948-22-0

5H-dibenz[b,f]azepine-5-carbonylchloride

Conditions
ConditionsYield
With triethylamine In toluene for 8h;
indole
120-72-9

indole

5H-dibenz[b,f]azepine-5-carbonylchloride
33948-22-0

5H-dibenz[b,f]azepine-5-carbonylchloride

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: potassium carbonate; copper(l) iodide; S-pyrrolidine-2-carbaldehyde / dimethyl sulfoxide / 24 h / 90 °C
2: polyphosphoric acid / 100 °C
3: triethylamine / toluene / 6 h
View Scheme
Multi-step reaction with 3 steps
1: potassium carbonate; copper(l) iodide; S-pyrrolidine-2-carbaldehyde / dimethyl sulfoxide / 24 h / 90 °C
2: polyphosphoric acid / 100 °C
3: triethylamine / toluene / 8 h
View Scheme
Multi-step reaction with 3 steps
1: palladium diacetate; tri-tert-butyl phosphine / o-xylene / 110 °C
2: polyphosphoric acid / 100 °C
3: triethylamine / toluene / 6 h
View Scheme
Multi-step reaction with 3 steps
1: palladium diacetate; tri-tert-butyl phosphine / o-xylene / 110 °C
2: polyphosphoric acid / 100 °C
3: triethylamine / toluene / 8 h
View Scheme
Multi-step reaction with 3 steps
1: dibutyltin dilaurate / toluene / 12 h / Reflux
2: methanesulfonic acid; phosphorus pentoxide / toluene / 6 h / 120 °C
3: toluene / 2.5 h / Reflux; Inert atmosphere
View Scheme
N-(2,2,2-trichloroacetyl)-5H-dibenz[b,f]azepine

N-(2,2,2-trichloroacetyl)-5H-dibenz[b,f]azepine

5H-dibenz[b,f]azepine-5-carbonylchloride
33948-22-0

5H-dibenz[b,f]azepine-5-carbonylchloride

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: sodium carbonate / water
2: triethylamine / toluene / 6 h
View Scheme
Multi-step reaction with 2 steps
1: sodium carbonate / water
2: triethylamine / toluene / 8 h
View Scheme
bromobenzene
108-86-1

bromobenzene

5H-dibenz[b,f]azepine-5-carbonylchloride
33948-22-0

5H-dibenz[b,f]azepine-5-carbonylchloride

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: palladium diacetate; tri-tert-butyl phosphine / o-xylene / 110 °C
2: polyphosphoric acid / 100 °C
3: triethylamine / toluene / 6 h
View Scheme
Multi-step reaction with 3 steps
1: palladium diacetate; tri-tert-butyl phosphine / o-xylene / 110 °C
2: polyphosphoric acid / 100 °C
3: triethylamine / toluene / 8 h
View Scheme
Multi-step reaction with 3 steps
1: dibutyltin dilaurate / toluene / 12 h / Reflux
2: methanesulfonic acid; phosphorus pentoxide / toluene / 6 h / 120 °C
3: toluene / 2.5 h / Reflux; Inert atmosphere
View Scheme
piperidine
110-89-4

piperidine

5H-dibenz[b,f]azepine-5-carbonylchloride
33948-22-0

5H-dibenz[b,f]azepine-5-carbonylchloride

N-(2-phenylethyl)-5H-dibenz[b,f]azepine-5-carboxamide
313554-34-6

N-(2-phenylethyl)-5H-dibenz[b,f]azepine-5-carboxamide

Conditions
ConditionsYield
With triethylamine In dichloromethane at 0 - 20℃; for 4h;94%
5H-dibenz[b,f]azepine-5-carbonylchloride
33948-22-0

5H-dibenz[b,f]azepine-5-carbonylchloride

dibenzoazepine
256-96-2

dibenzoazepine

Conditions
ConditionsYield
In acetonitrile electrolysis (Et4NClO4, Hg-dropelectrode);92%
5H-dibenz[b,f]azepine-5-carbonylchloride
33948-22-0

5H-dibenz[b,f]azepine-5-carbonylchloride

dimethyl amine
124-40-3

dimethyl amine

N,N-dimethyl-5H-dibenz[b,f]azepine-5-carboxamide
1548174-88-4

N,N-dimethyl-5H-dibenz[b,f]azepine-5-carboxamide

Conditions
ConditionsYield
With triethylamine In dichloromethane at 0 - 20℃; for 4h;88%
5H-dibenz[b,f]azepine-5-carbonylchloride
33948-22-0

5H-dibenz[b,f]azepine-5-carbonylchloride

diethylamine
109-89-7

diethylamine

N,N-diethyl-5H-dibenz[b,f]azepine-5-carboxamide
102080-94-4

N,N-diethyl-5H-dibenz[b,f]azepine-5-carboxamide

Conditions
ConditionsYield
With triethylamine In dichloromethane at 0 - 20℃; for 4h;86%
5H-dibenz[b,f]azepine-5-carbonylchloride
33948-22-0

5H-dibenz[b,f]azepine-5-carbonylchloride

5-Azidocarbonyldibenzazepin
116822-14-1

5-Azidocarbonyldibenzazepin

Conditions
ConditionsYield
With sodium azide; tetra-(n-butyl)ammonium iodide In chloroform; water for 30h; Heating;85%
5H-dibenz[b,f]azepine-5-carbonylchloride
33948-22-0

5H-dibenz[b,f]azepine-5-carbonylchloride

5,14-Dichlorcarbonyl-9b,9c,18b,18c-tetrahydrotetrabenzocyclobuta<1,2-d;3,4-d>bisazepin
117255-42-2

5,14-Dichlorcarbonyl-9b,9c,18b,18c-tetrahydrotetrabenzocyclobuta<1,2-d;3,4-d>bisazepin

Conditions
ConditionsYield
With benzophenone In acetone for 8h; Irradiation;84%
5H-dibenz[b,f]azepine-5-carbonylchloride
33948-22-0

5H-dibenz[b,f]azepine-5-carbonylchloride

methylamine
74-89-5

methylamine

5H-dibenzazepine-5-N-methyl carboxamide
41359-02-8

5H-dibenzazepine-5-N-methyl carboxamide

Conditions
ConditionsYield
With triethylamine In dichloromethane at 0 - 20℃; for 4h;84%
4-phenyl-1-piperazine
92-54-6

4-phenyl-1-piperazine

5H-dibenz[b,f]azepine-5-carbonylchloride
33948-22-0

5H-dibenz[b,f]azepine-5-carbonylchloride

(5H-dibenzo[b,f]azepin-5-yl)(4-phenylpiperazin-1-yl)methanone
1250431-00-5

(5H-dibenzo[b,f]azepin-5-yl)(4-phenylpiperazin-1-yl)methanone

Conditions
ConditionsYield
With triethylamine In 1,4-dioxane82%
4-Methoxyphenethylamine
55-81-2

4-Methoxyphenethylamine

5H-dibenz[b,f]azepine-5-carbonylchloride
33948-22-0

5H-dibenz[b,f]azepine-5-carbonylchloride

N-(2-(p-methoxyphenyl)ethyl)-5H-dibenz[b,f]azepine-5-carboxamide
1548174-78-2

N-(2-(p-methoxyphenyl)ethyl)-5H-dibenz[b,f]azepine-5-carboxamide

Conditions
ConditionsYield
With triethylamine In dichloromethane at 0 - 20℃; for 4h;82%
5H-dibenz[b,f]azepine-5-carbonylchloride
33948-22-0

5H-dibenz[b,f]azepine-5-carbonylchloride

2,2'-iminobis[ethanol]
111-42-2

2,2'-iminobis[ethanol]

N,N-di(2-hydroxyethyl)-5H-dibenz[b,f]azepine-5-carboxamide
1548175-03-6

N,N-di(2-hydroxyethyl)-5H-dibenz[b,f]azepine-5-carboxamide

Conditions
ConditionsYield
With triethylamine In dichloromethane at 0 - 20℃; for 4h;82%
pyrrolidine
123-75-1

pyrrolidine

5H-dibenz[b,f]azepine-5-carbonylchloride
33948-22-0

5H-dibenz[b,f]azepine-5-carbonylchloride

(5H-dibenzo[b,f]azepin-5-yl)(pyrrolidin-1-yl)methanone
294194-10-8

(5H-dibenzo[b,f]azepin-5-yl)(pyrrolidin-1-yl)methanone

Conditions
ConditionsYield
With triethylamine In 1,4-dioxane80%
With triethylamine In dichloromethane at 0 - 20℃; for 4h;71%
N,N',N'-trimethylenediamine
142-25-6

N,N',N'-trimethylenediamine

5H-dibenz[b,f]azepine-5-carbonylchloride
33948-22-0

5H-dibenz[b,f]azepine-5-carbonylchloride

N-[2-(dimethylamino)ethyl]-N-methyl-5H-dibenzo[b,f]azepine-5-carboxamide
1548174-95-3

N-[2-(dimethylamino)ethyl]-N-methyl-5H-dibenzo[b,f]azepine-5-carboxamide

Conditions
ConditionsYield
With triethylamine In dichloromethane at 0 - 20℃; for 4h;79%
5H-dibenz[b,f]azepine-5-carbonylchloride
33948-22-0

5H-dibenz[b,f]azepine-5-carbonylchloride

10-Brom-5-chlorcarbonyl-5H-dibenzazepin
143667-53-2

10-Brom-5-chlorcarbonyl-5H-dibenzazepin

Conditions
ConditionsYield
With bromine In chlorobenzene at 165 - 175℃; for 1h;78%
5H-dibenz[b,f]azepine-5-carbonylchloride
33948-22-0

5H-dibenz[b,f]azepine-5-carbonylchloride

10,11-Dibrom-5-chlorcarbonyl-5H-dibenzazepin
143667-54-3

10,11-Dibrom-5-chlorcarbonyl-5H-dibenzazepin

Conditions
ConditionsYield
With bromine In chlorobenzene at 170℃;78%
cyclohexylamine
108-91-8

cyclohexylamine

5H-dibenz[b,f]azepine-5-carbonylchloride
33948-22-0

5H-dibenz[b,f]azepine-5-carbonylchloride

N-cyclohexyl-5H-dibenz[b,f]azepine-5-carboxamide
381184-44-7

N-cyclohexyl-5H-dibenz[b,f]azepine-5-carboxamide

Conditions
ConditionsYield
With triethylamine In dichloromethane at 0 - 20℃; for 4h;78%
phenethylamine
64-04-0

phenethylamine

5H-dibenz[b,f]azepine-5-carbonylchloride
33948-22-0

5H-dibenz[b,f]azepine-5-carbonylchloride

N-(2-phenylethyl)-5H-dibenz[b,f]azepine-5-carboxamide
1548174-81-7

N-(2-phenylethyl)-5H-dibenz[b,f]azepine-5-carboxamide

Conditions
ConditionsYield
With triethylamine In dichloromethane at 0 - 20℃; for 4h;78%
5,10-bis(2-nitrobenzenesulfonyl)-5,10-diaza-1,14-tetradecanediamine
951010-97-2

5,10-bis(2-nitrobenzenesulfonyl)-5,10-diaza-1,14-tetradecanediamine

5H-dibenz[b,f]azepine-5-carbonylchloride
33948-22-0

5H-dibenz[b,f]azepine-5-carbonylchloride

C39H45N7O9S2

C39H45N7O9S2

Conditions
ConditionsYield
In dichloromethane at 20℃; for 2h;76%
In dichloromethane at 20℃;
4-HYDROXYPIPERIDINE
5382-16-1

4-HYDROXYPIPERIDINE

5H-dibenz[b,f]azepine-5-carbonylchloride
33948-22-0

5H-dibenz[b,f]azepine-5-carbonylchloride

5H-dibenz[b,f]azepin-5-yl-(4-hydroxypiperidin-1-yl)-methanone
1548175-06-9

5H-dibenz[b,f]azepin-5-yl-(4-hydroxypiperidin-1-yl)-methanone

Conditions
ConditionsYield
With triethylamine In dichloromethane at 0 - 20℃; for 4h;76%
morpholine
110-91-8

morpholine

5H-dibenz[b,f]azepine-5-carbonylchloride
33948-22-0

5H-dibenz[b,f]azepine-5-carbonylchloride

5H-dibenz[b,f]azepin-5-yl-4-morpholinyl-methanone
334500-64-0

5H-dibenz[b,f]azepin-5-yl-4-morpholinyl-methanone

Conditions
ConditionsYield
With triethylamine In dichloromethane at 0 - 20℃; for 4h;75%
di-n-propylamine
142-84-7

di-n-propylamine

5H-dibenz[b,f]azepine-5-carbonylchloride
33948-22-0

5H-dibenz[b,f]azepine-5-carbonylchloride

N,N-dipropyl-5H-dibenz[b,f]azepine-5-carboxamide
1548174-92-0

N,N-dipropyl-5H-dibenz[b,f]azepine-5-carboxamide

Conditions
ConditionsYield
With triethylamine In dichloromethane at 0 - 20℃; for 4h;74%
5H-dibenz[b,f]azepine-5-carbonylchloride
33948-22-0

5H-dibenz[b,f]azepine-5-carbonylchloride

aniline
62-53-3

aniline

N-phenyl-5H-dibenz[b,f]azepine-5-carboxamide
401581-13-3

N-phenyl-5H-dibenz[b,f]azepine-5-carboxamide

Conditions
ConditionsYield
With triethylamine In toluene for 2h; Reflux;74%
5H-dibenz[b,f]azepine-5-carbonylchloride
33948-22-0

5H-dibenz[b,f]azepine-5-carbonylchloride

tert-butylamine
75-64-9

tert-butylamine

N-tert-butyl-5H-dibenz[b,f]azepine-5-carboxamide
1548174-98-6

N-tert-butyl-5H-dibenz[b,f]azepine-5-carboxamide

Conditions
ConditionsYield
With triethylamine In dichloromethane at 0 - 20℃; for 4h;72%
5H-dibenz[b,f]azepine-5-carbonylchloride
33948-22-0

5H-dibenz[b,f]azepine-5-carbonylchloride

benzylamine
100-46-9

benzylamine

N-(phenylmethyl)-5H-dibenz[b,f]azepine-5-carboxamide
41359-01-7

N-(phenylmethyl)-5H-dibenz[b,f]azepine-5-carboxamide

Conditions
ConditionsYield
With triethylamine In dichloromethane at 0 - 20℃; for 4h;71%
5-decyne
1942-46-7

5-decyne

5H-dibenz[b,f]azepine-5-carbonylchloride
33948-22-0

5H-dibenz[b,f]azepine-5-carbonylchloride

C25H27NO
1235712-80-7

C25H27NO

Conditions
ConditionsYield
With bis(1,5-cyclooctadiene)diiridium(I) dichloride; cyclo-octa-1,5-diene In o-xylene for 20h; Inert atmosphere; Reflux;70%
p-hydroxycyclohexylamine
6850-65-3

p-hydroxycyclohexylamine

5H-dibenz[b,f]azepine-5-carbonylchloride
33948-22-0

5H-dibenz[b,f]azepine-5-carbonylchloride

N-(4-hydroxycyclohexyl)-5H-dibenz[b,f]azepine-5-carboxamide
1548175-08-1

N-(4-hydroxycyclohexyl)-5H-dibenz[b,f]azepine-5-carboxamide

Conditions
ConditionsYield
With triethylamine In dichloromethane at 0 - 20℃; for 4h;70%
5H-dibenz[b,f]azepine-5-carbonylchloride
33948-22-0

5H-dibenz[b,f]azepine-5-carbonylchloride

N-butylamine
109-73-9

N-butylamine

N-n-butyl-5H-dibenz[b,f]azepine-5-carboxamide
1548174-90-8

N-n-butyl-5H-dibenz[b,f]azepine-5-carboxamide

Conditions
ConditionsYield
With triethylamine In dichloromethane at 0 - 20℃; for 4h;69%
5H-dibenz[b,f]azepine-5-carbonylchloride
33948-22-0

5H-dibenz[b,f]azepine-5-carbonylchloride

isopropylamine
75-31-0

isopropylamine

N-(isopropyl)-5H-dibenz[b,f]azepine-5-carboxamide
1548174-75-9

N-(isopropyl)-5H-dibenz[b,f]azepine-5-carboxamide

Conditions
ConditionsYield
With triethylamine In dichloromethane at 0 - 20℃; for 4h;67%

33948-22-0Relevant articles and documents

Synthesis and Biological Evaluation of Celastrol Derivatives with Improved Cytotoxic Selectivity and Antitumor Activities

Feng, Jia-Hao,He, Qi-Wei,Hou, Ji-Qin,Hu, Xiao-Long,Long, Huan,Wang, Bao-Lin,Wang, Hao,Wang, Quan,Wang, Rong,Ye, Wen-Cai,Zhang, Li-Xin,Zhang, Xiao-Qi

, p. 1954 - 1966 (2021/07/20)

Cdc37 associates kinase clients to Hsp90 and promotes the development of cancers. Celastrol, a natural friedelane triterpenoid, can disrupt the Hsp90-Cdc37 interaction to provide antitumor effects. In this study, 31 new celastrol derivatives, 2a - 2d , 3a - 3g , and 4a - 4t , were designed and synthesized, and their Hsp90-Cdc37 disruption activities and antiproliferative activities against cancer cells were evaluated. Among these compounds, 4f , with the highest tumor cell selectivity (15.4-fold), potent Hsp90-Cdc37 disruption activity (IC50= 1.9 μM), and antiproliferative activity against MDA-MB-231 cells (IC50= 0.2 μM), was selected as the lead compound. Further studies demonstrated 4f has strong antitumor activities both in vitro and in vivo through disrupting the Hsp90-Cdc37 interaction and inhibiting angiogenesis. In addition, 4f exhibited less toxicity than celastrol and showed a good pharmacokinetics profile in vivo. These findings suggest that 4f may be a promising candidate for development of new cancer therapies.

Method for synthesizing carbamazepine

-

Paragraph 0008; 0009; 0010, (2018/12/13)

The invention discloses a method for synthesizing carbamazepine. The method takes iminodibenzyl and chlorobenzene as raw materials and comprises the following steps: introducing triphosgene to obtainacyl chloride, performing bromination with bromine to obtain bromide, performing ammoniation with ammonium hydroxide to obtain a crude product of the carbamazepine, and finally, refining the crude product with ethanol to obtain a finished product of the carbamazepine. The acyl chlorination, bromination and ammoniation adopt chlorobenzene as a reaction solvent to reduce consumption of other solvents; in the acyl chlorination reaction, the triphosgene replaces phosgene to solve the problems of safety and environmental protection in the process; the obtained acyl chloride is not separated and isdirectly subjected to bromination dehydrogenation and ammoniation reaction to lower the operation cost; the yield of each step of the synthesis process is 93% or higher, thereby improving the production efficiency and lowering the production cost; and the synthesis process adopts self-designed novel closed equipment to reduce the consumption of chlorobenzene and ethanol, thereby being suitable forindustrial production.

N-heterocyclic (4-phenylpiperazin-1-yl)methanones derived from phenoxazine and phenothiazine as highly potent inhibitors of tubulin polymerization

Prinz, Helge,Ridder, Ann-Kathrin,Vogel, Kirsten,B?hm, Konrad J.,Ivanov, Igor,Ghasemi, Jahan B.,Aghaee, Elham,Müller, Klaus

, p. 749 - 766 (2017/02/05)

We report here a series of 27 10-(4-phenylpiperazin-1-yl)methanones derived from tricyclic heterocycles which were screened for effects on tumor cell growth, inhibition of tubulin polymerization, and induction of cell cycle arrest. Several analogues, among them the 10-(4-(3-methoxyphenyl)piperazine-1-carbonyl)-10H-phenoxazine-3-carbonitrile (16o), showed excellent antiproliferative properties, with low nanomolar GI50 values (16o, mean GI50 of 3.3 nM) against a large number (93) of cancer cell lines. Fifteen compounds potently inhibited tubulin polymerization. Analysis of cell cycle by flow cytometry revealed that inhibition of tumor cell growth was related to an induction of G2/M phase cell cycle blockade. Western blotting and molecular docking studies suggested that these compounds bind efficiently to β-tubulin at the colchicine binding site. Our studies demonstrate the suitability of the phenoxazine and phenothiazine core and also of the phenylpiperazine moiety for the development of novel and potent tubulin polymerization inhibitors.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 33948-22-0